|
|
 |
INTRODUCTION This free CME activity is based on a symposium taped in Philadelphia, Pennsylvania, on November 10, 2006. Persons who attended the symposium are NOT eligible for AMA PRA Category 1 Credit™ for completing this enduring material. Please note that the course is accredited only for physicians (MD, DO, or equivalent). All other participants receive a certificate of completion. In accordance with the ACCME Essential Areas and Policies regarding commercial support, participants are advised that 1 or more presentations in this continuing medical education activity may contain references to off-label or unapproved uses of drugs or devices. Participants should note that the use of these agents outside current approved labeling is considered experimental and are advised to consult prescribing information for these products. This CME activity was planned and produced in accordance with the ACCME Essential Areas and Policies.
Learning Objectives Upon completion of this activity, participants should be able to
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide contributing medical education for physicians. The ACAAI designates this educational activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Disclosure Policy ACAAI requires that those involved with content development and/or presentation disclose to the participant any significant financial interest or other relationship with (1) the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) any commercial supporters of the activity. Off-label Discussion This CME activity may include discussions regarding the use of medications which may be outside the approved labeling for these products. Physicians should consult the current prescribing information for these products. The ACAAI requires the speaker to disclose that the product is not labeled for the use under discussion. Compliance is documentation that demonstrates the provider has a practice in place to make this requirement known to the faculty. Faculty Disclosure Allan T. Luskin, MD Andrea J. Apter, MD, MSc Bruce G. Bender, PhD Rita K. Cydulka, MD, MS Instructions to Participants Course participants must view the entire presentation and complete the course evaluation in order to receive continuing medical education credit. No fees are charged to participate in the program or to receive the certificate. Full instructions are available on the user instructions page. Disclaimer The opinions expressed herein are those of the faculty and do not necessarily represent the views of the grantor, accrediting body, or publisher. Please review complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects, before administering pharmacologic therapy to patients. Medicine is a constantly changing science, and clearly established therapies are not always available for every condition. New research findings necessitate continual changes in drug and treatment therapies. Reasonable efforts have been made to provide up-to-date, accurate information that is within generally accepted medical standards at the time of publication. However, as medical science is ever evolving, and human error is always possible, the educational supporter, provider, and publisher (or any other involved party) do not guarantee total accuracy or comprehensiveness of the information in this article, and they are not responsible for omissions or errors, or the results of using information provided in this course. Participants should confirm the accuracy of the information in this activity from other sources. In particular, all drug doses, indications, and contraindications should be confirmed in package inserts. Click here to view minimum system requirements.
|
